Revolution Medicines Inc. Common Stock vs Vanguard Total International Stock Index Fund ETF — how do they compare? Revolution Medicines Inc. Common Stock trades at $188.5 (market cap $40.32B), while Vanguard Total International Stock Index Fund ETF trades at $84.53 (market cap $665.70B). The key difference: Vanguard Total International Stock Index Fund ETF is far larger — about 16.5× Revolution Medicines Inc. Common Stock's market cap, and Vanguard Total International Stock Index Fund ETF is more actively traded (4,864,744 versus 4,855,734). Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Vanguard Total International Stock Index Fund ETF for 55 Days on average.
| RVMD | VXUS | |
|---|---|---|
Market Cap | $40.32B | $665.70B |
Volume | 4,855,734 | 4,864,744 |
Sector | Health | Sector/Thematic |
52-Week High | $221.15 | $88.41 |
52-Week Low | $47.50 | $72.17 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $37.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VXUS trades at $84.78, down 1.19% with a bearish technical signal from moving averages. The ETF provides broad international stock exposure outside the U.S., with institutional buying interest noted in recent SEC filings. Technical indicators show neutral oscillators but bearish momentum signals from ADX readings.
The fund offers diversification benefits as a core international holding, though recent performance faces headwinds. Key risks include currency fluctuations and emerging market volatility. Long-term outlook remains positive for global equity exposure, supported by Vanguard's low-cost structure and comprehensive market coverage.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →